Loss of Expression of the WNT/β-Catenin-Signaling Pathway Transcription Factors Lymphoid Enhancer Factor-1 (LEF-1) and T Cell Factor-1 (TCF-1) in a Subset of Peripheral T Cell Lymphomas
- 1 May 2003
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 162 (5) , 1539-1544
- https://doi.org/10.1016/s0002-9440(10)64287-3
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Aberrant Nuclear Localization and Gene Mutation of β-catenin in Low-Grade Adenocarcinoma of Fetal Lung Type: Up-Regulation of the Wnt Signaling Pathway May Be a Common Denominator for the Development of Tumors that Form MorulesLaboratory Investigation, 2002
- TranscriptionCell, 2002
- Analysis of Octamer-Binding Transcription Factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in LymphomasLaboratory Investigation, 2002
- Characterization of a Novel Human Anaplastic Large Cell Lymphoma Cell Line Tumorigenic in SCID MiceLeukemia & Lymphoma, 2002
- Redundant Regulation of T Cell Differentiation and TCRα Gene Expression by the Transcription Factors LEF-1 and TCF-1Immunity, 1998
- Opposite role for interleukin‐4 and interferon‐γ on CD30 and lymphocyte activation gene‐3 (LAG‐3) expression by activated naive T cellsEuropean Journal of Immunology, 1997
- Stabilization of β-Catenin by Genetic Defects in Melanoma Cell LinesScience, 1997
- Functional diversity of helper T lymphocytesNature, 1996
- Involvement of transcription factors TCF-1 and GATA-3 in the initiation of the earliest step of T cell development in the thymus.The Journal of Experimental Medicine, 1996
- IL-2 promoter-driven lacZ expression as a monitoring tool for IL-2 expression in primary T cells of transgenic miceInternational Immunology, 1994